Details

NameSymbolSector
UNICHEM LABORATORIES LTD.UNICHEMLABPharmaceuticals
Open
548.2
High
548.2
Low
531.5
Close
540.2
Volume
95319
Exchange
nse
Time
14-Aug-2026

Outlook

Score:

1.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofUnichemLaboratoriesis
None
EstimatedStoplossofUnichemLaboratoriesis
548.2
UnichemLaboratorieshasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofUnichemLaboratoriesis
Unpredictableℹ
.

Trend

UnichemLaboratoriesisin
Sideways trendℹ
.
PriceofUnichemLaboratoriesis
Upℹ
by

7.38

%.
Target
Buy@

288.09

Sell@

636.91

Current@

540.2

Volume

ThetradevolumesofUnichemLaboratorieshavebecome
Deficientℹ
ThoughthevolumetrendforUnichemLaboratoriesappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofUnichemLaboratoriesis

Down

by

79.52

%

Valuation

ThecurrentmarketpriceofUnichemLaboratoriesis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth3569crandtotalassetsworth3569cr,thebalancesheetofUnichemLaboratoriesis:
Balancedℹ
.
Cashflow
UnichemLaboratorieshas
Badℹ
cashflowbecausethereis

Shortage

of

₹ 65cr

.Itis
Downℹ
by

103.13

%.
1.62% i.e. ₹ 7cr spent in operatingℹ
55.92% i.e. ₹ 241cr spent in investingℹ
42.46% i.e. ₹ 183cr earned in financingℹ
0% in otherℹ
UnichemLaboratorieshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 32cr

.Itis
Downℹ
by

143.24

%.
8.99% i.e. ₹ 16cr earned in operatingℹ
28.09% i.e. ₹ 50cr earned in investingℹ
59.55% i.e. ₹ 106cr spent in financingℹ
3.37% i.e. ₹ 6cr earned in otherℹ
Income
TheincomeofUnichemLaboratoriesis

₹ 599cr

and

Loss

is:

₹ 11cr

UnichemLaboratoriesLossesincreasedby:

10

%andIncomeisUpby:

12.38

%
TheincomeofUnichemLaboratoriesis

₹ 533cr

and

Loss

is:

₹ 10cr

UnichemLaboratoriesLossesincreasedby:

119.23

%andIncomeisDownby:

10.57

%
TheincomeofUnichemLaboratoriesis

₹ 596cr

and

Profit

is:

₹ 52cr

UnichemLaboratoriesProfitisdownby:

8.77

%andIncomeisUpby:

9.16

%
By using this site you agree to the use of cookies to deliver a better site experience.